Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is an allylamine antifungal presented as a topical formulation for topical use. It treats dermatophyte skin infections such as athlete's foot, ringworm and jock itch in adults and children. GNH USA supplies Lamisil Once as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil Once is an allylamine antifungal used to treat superficial dermatophyte infections of the skin. - Tinea pedis (athlete's foot): reduces fungal growth and clears the infection. - Tinea corporis (ringworm): alleviates lesions and promotes skin healing. - Tinea cruris (jock itch): resolves itching, redness and rash associated with the infection.

Terbinafine may cause local and systemic reactions when applied to the skin.

Common Side Effects: - Mild skin irritation at the application site. - Itching or burning sensation. - Redness or erythema. - Dryness or peeling of the treated area. - Slight itching elsewhere on the body.

Serious or Rare Side Effects: - Severe allergic reaction (hives, swelling, difficulty breathing). - Contact dermatitis with blistering. - Persistent rash or ulceration. - Unexplained fever. - Hepatotoxicity (rare, indicated by jaundice or abnormal liver tests).

Before using Lamisil Once, consider the following precautions: - Avoid application to broken or inflamed skin: limit use to intact areas. - Do not use on extensive body surface: follow prescriber guidance for area size. - Monitor for signs of allergic reaction: discontinue if severe rash or swelling occurs. - Pregnant or breastfeeding individuals should consult a healthcare professional before use. - Keep out of reach of children: accidental ingestion may cause systemic effects. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Terbinafine may interact with other substances applied to the skin or absorbed systemically.

Major Interactions (Avoid): - Concurrent use of other topical antifungals containing azoles: may increase irritation risk. - Systemic terbinafine therapy: avoid duplicate topical exposure.

Moderate Interactions (Monitor Closely): - Topical corticosteroids applied to the same area: may reduce antifungal efficacy. - Products containing alcohol or harsh solvents: may enhance skin irritation. - Use with occlusive dressings: may increase drug absorption and local side effects.